Related Experiment Video
Updated: Jan 11, 2026

Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays
Published on: August 13, 2017
Synuclein Proteoforms: Role in Health and Disease
Fatima Tu Zahra1, Hooreen Kayani1, Samra Noreen1
1Department of Biomedical Engineering and Sciences, School of Mechanical and Manufacturing Engineering, National University of Sciences and Technology, H-12, Islamabad, 44000, Pakistan.
Synuclein proteoforms, diverse protein variants, are central to neurodegenerative diseases like Parkinson's. Understanding their structure and function is key to developing targeted treatments for synucleinopathies.
Area of Science:
- Neurobiology
- Molecular Medicine
- Protein Biochemistry
Background:
- Synucleins (α, β, γ) are intrinsically disordered proteins vital for neuronal function.
- Pathological aggregation of synucleins underlies synucleinopathies such as Parkinson's disease.
- The full biological significance of diverse synuclein proteoforms remains incompletely understood.
Purpose of the Study:
- To systematically review the structural and functional diversity of synuclein proteoforms.
- To explore the roles of β- and γ-synucleins in modulating α-synuclein aggregation.
- To integrate knowledge on synuclein proteoforms, their interactions, aggregation, and implications in neurodegeneration and beyond.
Main Methods:
- Systematic literature review and knowledge synthesis.
- Analysis of recent advancements in molecular imaging and proteomic techniques.
- Investigation of regulatory effects and aggregation pathways of synuclein proteoforms.
Main Results:
- Synuclein proteoforms exhibit significant structural and functional heterogeneity.
- β- and γ-synucleins influence α-synuclein aggregation, with distinct physiological roles.
- Synucleins are implicated in both central nervous system and peripheral tissue functions, including immune regulation.
Conclusions:
- Understanding synuclein proteoform complexity is crucial for developing targeted therapies for synucleinopathies.
- Advances in characterization techniques facilitate the study of synuclein proteoforms.
- Bridging translational research and molecular neurobiology is essential for addressing synuclein-related disorders.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Neural Regulation
Lysosomal Hydrolases

